Racotumomab
- CAS No.
- 946832-34-4
- Chemical Name:
- Racotumomab
- Synonyms
- Racotumomab;Racotumomab (anti-GM3);Research Grade Racotumomab;Research Grade Racotumomab (DGK11201)
- CBNumber:
- CB18080773
- Molecular Formula:
- Molecular Weight:
- 0
- MDL Number:
- MOL File:
- Mol file
- MSDS File:
- SDS
| form | Liquid |
|---|---|
| color | Colorless to light yellow |
| FDA UNII | 52G405U1E5 |
| NCI Drug Dictionary | racotumomab |
Racotumomab price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| ChemScene | CS-0617497 | Racotumomab ≥99.0% | 946832-34-4 | 1mg | $217 | 2026-06-04 | Buy |
| ChemScene | CS-0617497 | Racotumomab ≥99.0% | 946832-34-4 | 5mg | $650 | 2026-06-04 | Buy |
| ChemScene | CS-0617497 | Racotumomab ≥99.0% | 946832-34-4 | 10mg | $1040 | 2026-06-04 | Buy |
| Biorbyt Ltd | orb1944776 | Racotumomab Antibody >95% | 946832-34-4 | 1mg | $210 | 2026-05-06 | Buy |
| Biorbyt Ltd | orb1944776 | Racotumomab Antibody >95% | 946832-34-4 | 5mg | $540 | 2026-05-06 | Buy |
Racotumomab Chemical Properties, Uses, Production
Uses
Racotumomab (Anti-Human NGcGM3 Recombinant Antibody) is an anti-idiotype monoclonal antibody (MAb). Racotumomab reacts to Neu-glycolyl (NeuGc)-containing gangliosides, sulfatides, and other antigens expressed in tumors. Racotumomab is an active anticancer agent for lung cancer[1][2][3].
in vivo
Racotumomab (50 μg/dose, i.p.) together with Keyhole limpet hemocyanin (KLH) inhibits tumor growth in F3II cell (s.c.) mammary tumor mice model[2].
Racotumomab (50 μg/dose, s.c.) together with Pemetrexed (100 mg/kg) is highly effective against lung nodules in 3LL cell (s.c.) mice xenograft[3].
Racotumomab (50-200 μg/dose, s.c.) shows no significant antitumor effect in 3LL cell (s.c.) mice xenograft[3].
| Animal Model: | 3LL cell (s.c.) mice xenograft[3] |
| Dosage: | 50 μg/dose, together with Pemetrexed (100 mg/kg) |
| Administration: | Subcutaneous injection (s.c.) |
| Result: | Reduced lung nodules. |
References
[1] Vázquez AM, et al. Racotumomab: an anti-idiotype vaccine related to N-glycolyl-containing gangliosides - preclinical and clinical data. Front Oncol. 2012 Oct 23;2:150. DOI:10.3389/fonc.2012.00150
[2] Gajdosik Z. Racotumomab - a novel anti-idiotype monoclonal antibody vaccine for the treatment of cancer. Drugs Today (Barc). 2014 Apr;50(4):301-7. DOI:10.1358/dot.2014.50.4.2116670
[3] Segatori VI, et al. Preclinical evaluation of racotumomab, an anti-idiotype monoclonal antibody to N-glycolyl-containing gangliosides, with or without chemotherapy in a mouse model of non-small cell lung cancer. Front Oncol. 2012 Nov 8;2:160. DOI:10.3389/fonc.2012.00160
[4] Truong CS, et al. Oncolytic Vaccinia Virus in Lung Cancer Vaccines. Vaccines (Basel). 2022 Feb 4;10(2):240. DOI:10.3390/vaccines10020240
Racotumomab Preparation Products And Raw materials
Raw materials
Preparation Products
Racotumomab Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Shanghai YuanYe Biotechnology Co., Ltd. | 15026964105 | 2881489226@qq.com | China | 89667 | 60 |
| ShangHai Biochempartner Co.,Ltd | 177-54423994 17754423994 | 2853530910@QQ.com | China | 8000 | 62 |
| TargetMol Chemicals Inc. | +1-781-999-5354; +1-00000000000 | marketing@targetmol.com | United States | 32431 | 58 |
| Guangzhou Hongyuan Chemical Co.,Ltd | 15817493340 | 981810490@qq.com | China | 1577 | 58 |
| Wuhan Chemstan Biotechnology Co., Ltd. | 027-65317797 15926423062 | 422450190@qq.com | China | 10305 | 58 |
| TargetMol Chemicals Inc. | 4008200310 15002144251 | marketing@tsbiochem.com | China | 24951 | 58 |
| Biolab Reagents | 027-65279366 18108604356 | products@biolabreagent.com | China | 9864 | 58 |
| Wuhan Jingkangen Biomedical Technology Co., Ltd | 13720134139 086-15871494362 13720134139 | orders@jknbiochem.com | China | 7283 | 58 |
| Shanghai Yifei Biotechnology Co. , Ltd. | 021-65675885 18964387627 | customer_service@efebio.com | China | 11963 | 58 |
| Wuhan Acumen Bio-Technology Co.,ltd | 027-027-16602739303 16602739303 | 673003916@qq.com | China | 4593 | 58 |
View Latest Price from Racotumomab manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
 |
2026-07-30 | Racotumomab
946832-34-4
|
$130.00-636.00 | > 95% | 10g | TargetMol Chemicals Inc. |
-
- Racotumomab
946832-34-4
- $130.00-636.00
- > 95%
- TargetMol Chemicals Inc.
